Cardiovascular Disease

We pioneer innovative technologies that help improve treatment options for underserved patients suffering from cardiovascular disease, including coronary artery disease, peripheral artery disease and refractory angina.

Shockwave Coronary IVL for Coronary Artery Disease

Shockwave coronary Intravascular Lithotripsy (IVL) is a paradigm-shifting device allowing interventional cardiologists to bridge the gap between predictably safe and consistently effective coronary calcium modification in patients suffering from calcified coronary artery disease (CAD). Shockwave coronary IVL disrupts coronary calcium through its unique mechanism of action (MOA), modifying various calcium morphologies in a safe, effective and intuitive manner prior to stent deployment. 

Shockwave IVL for Peripheral Artery Disease

Shockwave Intravascular Lithotripsy (IVL) is your peripheral powerhouse when it comes to treating calcified peripheral artery disease (PAD). Our safe, effective mechanism of action (MOA) delivers consistent results and powerful calcium-cracking capabilities — even in the hardest-to-reach vessels. Dive deeper into peripheral IVL above and below the knee and how it can be used to enable access of transcatheter aortic valve replacement (TAVR) and endovascular aneurysm repair (EVAR).

Coronary Sinus Reduction for Refractory Angina

Reducing pain. Restoring hope. Millions of patients with coronary artery disease (CAD) suffer from refractory angina despite receiving optimal medical therapy. Shockwave Reducer is designed to treat the symptoms of refractory angina through a permanent, controlled narrowing of the coronary sinus.

Browse our product portfolio for treatment options from the heart to above and below the knee